%Start Spinal muscular atrophy (SMA) life expectancy: Types 0, 1, 2, 3, and 4 Health ConditionsHealth ConditionsAlzheimer's & DementiaAnxietyArthritisAsthma & AllergiesBreast CancerCancerCardiovascular HealthCOVID-19Dermatology & SkincareDiabetesEnvironment & SustainabilityExercise & FitnessEye HealthHeadache & MigraineHealth EquityHIV & AIDSHuman BiologyInflammatory Bowel DiseaseLeukemiaLGBTQIA+Men's HealthMental HealthMultiple Sclerosis (MS)NutritionParkinson's DiseasePsoriasisSexual HealthWomen's HealthDiscoverNewsLatest NewsOriginal SeriesMedical MythsHonest NutritionThrough My EyesNew Normal HealthPodcastsHow to understand chronic painWhat is behind vaccine hesitancy?The amazing story of hepatitis C, from discovery to cureNew directions in dementia researchCan psychedelics rewire a depressed, anxious brain?Why climate change matters for human healthToolsGeneral HealthDrugs A-ZHealth HubsHealth ToolsBMI Calculators and ChartsBlood Pressure Chart: Ranges and GuideBreast Cancer: Self-Examination GuideSleep CalculatorHealth ProductsAffordable Therapy OptionsBlood Pressure MonitorsDiabetic SuppliesFitness TrackersHome GymsGreen Cleaning ProductsHow to Shop for CBDQuizzesRA Myths vs FactsType 2 Diabetes: Managing Blood SugarAnkylosing Spondylitis Pain: Fact or FictionConnectAbout Medical News TodayWho We AreOur Editorial ProcessContent IntegrityConscious LanguageNewslettersSign UpFollow UsMedical News TodayHealth ConditionsDiscoverToolsConnectSubscribe
What is the life expectancy for spinal muscular atrophy SMA Medically reviewed by Heidi Moawad, M.D. — By Zawn Villines on September 12, 2022Spinal muscular atrophy (SMA) is the leading genetic cause of infant mortality. Historically, the average life expectancy for infants diagnosed before 6 months was under 2 years, but new treatments can prolong their lifespan.
thumb_upLike (0)
commentReply (1)
shareShare
visibility634 views
thumb_up0 likes
comment
1 replies
N
Natalie Lopez 3 minutes ago
The above information comes from a 2018 study in the Journal of Pediatrics and Child Health. It is i...
E
Elijah Patel Member
access_time
2 minutes ago
Wednesday, 07 May 2025
The above information comes from a 2018 study in the Journal of Pediatrics and Child Health. It is important to note that different types of SMA have different outlooks.
thumb_upLike (36)
commentReply (1)
thumb_up36 likes
comment
1 replies
J
Julia Zhang 2 minutes ago
Types 0 and 1, the most severe forms, have a very short life expectancy without treatment. However, ...
J
Jack Thompson Member
access_time
6 minutes ago
Wednesday, 07 May 2025
Types 0 and 1, the most severe forms, have a very short life expectancy without treatment. However, newer treatments can prolong the life of someone with type 0 and type 1.
thumb_upLike (9)
commentReply (1)
thumb_up9 likes
comment
1 replies
Z
Zoe Mueller 6 minutes ago
Type 2 can cause significant disability, which can increase the risk of a shortened lifespan. Types ...
C
Charlotte Lee Member
access_time
12 minutes ago
Wednesday, 07 May 2025
Type 2 can cause significant disability, which can increase the risk of a shortened lifespan. Types 3 and 4 do not substantially affect life expectancy, but complications can sometimes be life threatening. Read on to learn more about SMA life expectancy, factors that affect it, how to improve it, and more.
thumb_upLike (35)
commentReply (2)
thumb_up35 likes
comment
2 replies
M
Mason Rodriguez 5 minutes ago
SMA life expectancy
Share on PinterestKathrin Ziegler/Getty ImagesSMA is a group of diseases that ...
N
Noah Davis 7 minutes ago
Types 0, 1, and 2 cause weakness in the muscles that control breathing, shortening a person’s life...
J
Joseph Kim Member
access_time
10 minutes ago
Wednesday, 07 May 2025
SMA life expectancy
Share on PinterestKathrin Ziegler/Getty ImagesSMA is a group of diseases that harm motor neurons in the brainstem and spinal cord. It causes muscle weakness and dysfunction that can affect a person’s ability to move, sit, breathe, eat, walk, and talk. There are five types ranging from 0 to 4, and a person’s life expectancy mainly depends on the type of disease they have.
thumb_upLike (16)
commentReply (1)
thumb_up16 likes
comment
1 replies
J
Joseph Kim 10 minutes ago
Types 0, 1, and 2 cause weakness in the muscles that control breathing, shortening a person’s life...
D
David Cohen Member
access_time
12 minutes ago
Wednesday, 07 May 2025
Types 0, 1, and 2 cause weakness in the muscles that control breathing, shortening a person’s lifespan. Type 2 has less of an effect on respiration than types 0 and 1.
thumb_upLike (15)
commentReply (0)
thumb_up15 likes
E
Ella Rodriguez Member
access_time
14 minutes ago
Wednesday, 07 May 2025
Conversely, types 3 and 4 can cause various disabilities, including mobility impairments, but they do not significantly affect lifespan. While historical data point to a very shortened lifespan for infants with types 0, 1, and 2, new gene therapies, such as Zolgensma (onasemnogene abeparvovec-xioi), can prolong life expectancy.
thumb_upLike (21)
commentReply (0)
thumb_up21 likes
C
Chloe Santos Moderator
access_time
40 minutes ago
Wednesday, 07 May 2025
They prevent further lung damage by slowing the progression of the disease. Gene therapy is an approved treatment for children with an SMA diagnosis who are younger than 2 years old and have mutations in the survival 6516 motor neuron 1 (SMN1) gene.
thumb_upLike (37)
commentReply (3)
thumb_up37 likes
comment
3 replies
Z
Zoe Mueller 38 minutes ago
Researchers have not proven it to be beneficial for people with SMA who are older than 2 years. The ...
D
David Cohen 30 minutes ago
These two medications restore the missing SMA protein. They work similarly, so doctors do not need t...
Researchers have not proven it to be beneficial for people with SMA who are older than 2 years. The injectable medications Spinraza (nusinerson) and Evrysdi (risdiplan) work differently than gene therapy and have approval for use in children and adults.
thumb_upLike (25)
commentReply (3)
thumb_up25 likes
comment
3 replies
I
Isaac Schmidt 27 minutes ago
These two medications restore the missing SMA protein. They work similarly, so doctors do not need t...
I
Isaac Schmidt 26 minutes ago
SMA type 0
Type 0 causes symptoms immediately at birth. Before birth, it can also cause symptoms, su...
These two medications restore the missing SMA protein. They work similarly, so doctors do not need to combine them, but they can use the medications with gene therapy. Life expectancy by type
There are five types of SMA, and their outlook and treatment options vary by type.
thumb_upLike (3)
commentReply (2)
thumb_up3 likes
comment
2 replies
M
Mason Rodriguez 19 minutes ago
SMA type 0
Type 0 causes symptoms immediately at birth. Before birth, it can also cause symptoms, su...
R
Ryan Garcia 16 minutes ago
Although type 0 is the most severe form of SMA, it is also the rarest. Infants with this type do not...
W
William Brown Member
access_time
33 minutes ago
Wednesday, 07 May 2025
SMA type 0
Type 0 causes symptoms immediately at birth. Before birth, it can also cause symptoms, such as very limited movements of the growing fetus. Most notably, it can lead to respiratory failure.
thumb_upLike (39)
commentReply (3)
thumb_up39 likes
comment
3 replies
I
Isaac Schmidt 11 minutes ago
Although type 0 is the most severe form of SMA, it is also the rarest. Infants with this type do not...
C
Charlotte Lee 3 minutes ago
Emerging treatments, including gene therapy, may prolong life expectancy. However, these treatments ...
Although type 0 is the most severe form of SMA, it is also the rarest. Infants with this type do not typically live past their first few months of life, and some do not survive past birth.
thumb_upLike (32)
commentReply (2)
thumb_up32 likes
comment
2 replies
D
Daniel Kumar 10 minutes ago
Emerging treatments, including gene therapy, may prolong life expectancy. However, these treatments ...
L
Lily Watson 2 minutes ago
SMA type 1
Type 1 is the most common form of the disease. According to existing data, an infant with...
L
Luna Park Member
access_time
39 minutes ago
Wednesday, 07 May 2025
Emerging treatments, including gene therapy, may prolong life expectancy. However, these treatments are new and work best when they begin before symptoms become severe. It is not clear how they may help infants with type 0 SMA.
thumb_upLike (5)
commentReply (1)
thumb_up5 likes
comment
1 replies
I
Isabella Johnson 15 minutes ago
SMA type 1
Type 1 is the most common form of the disease. According to existing data, an infant with...
Z
Zoe Mueller Member
access_time
42 minutes ago
Wednesday, 07 May 2025
SMA type 1
Type 1 is the most common form of the disease. According to existing data, an infant with this type has an average lifespan of 2 years or less. Symptoms usually begin between 3 and 6 months after birth.
thumb_upLike (41)
commentReply (2)
thumb_up41 likes
comment
2 replies
S
Sebastian Silva 14 minutes ago
Breathing difficulties are common and, in many cases, eventually fatal. As mentioned earlier, new tr...
T
Thomas Anderson 34 minutes ago
Treatment must begin early in life and before the onset of severe symptoms. SMA type 2
Type 2 causes...
S
Scarlett Brown Member
access_time
60 minutes ago
Wednesday, 07 May 2025
Breathing difficulties are common and, in many cases, eventually fatal. As mentioned earlier, new treatments may prolong a person’s life. However, they will not reverse the symptoms a person already has.
thumb_upLike (11)
commentReply (3)
thumb_up11 likes
comment
3 replies
D
Daniel Kumar 2 minutes ago
Treatment must begin early in life and before the onset of severe symptoms. SMA type 2
Type 2 causes...
J
Jack Thompson 24 minutes ago
According to current data, 70% live to the age of 25 years, and some live even longer. As with the m...
Treatment must begin early in life and before the onset of severe symptoms. SMA type 2
Type 2 causes symptoms beginning at 6–18 months of age. Infants and children with this type usually have more mobility, including the ability to sit, and do not experience the same level of disability as those with types 0 and 1.
thumb_upLike (45)
commentReply (1)
thumb_up45 likes
comment
1 replies
N
Nathan Chen 24 minutes ago
According to current data, 70% live to the age of 25 years, and some live even longer. As with the m...
L
Lucas Martinez Moderator
access_time
51 minutes ago
Wednesday, 07 May 2025
According to current data, 70% live to the age of 25 years, and some live even longer. As with the more severe forms of SMA, emerging treatments may prolong the life expectancy of someone with SMA type 2.
thumb_upLike (47)
commentReply (2)
thumb_up47 likes
comment
2 replies
L
Luna Park 8 minutes ago
However, these treatments are new, so it is unclear how much they can affect lifespan. SMA type 3
SM...
S
Sophie Martin 38 minutes ago
Some individuals with type 3 have other disabilities or need assistive devices, such as wheelchairs,...
E
Ethan Thomas Member
access_time
36 minutes ago
Wednesday, 07 May 2025
However, these treatments are new, so it is unclear how much they can affect lifespan. SMA type 3
SMA type 3 causes fewer mobility impairments. People with this form often can walk and do not typically have breathing difficulties.
thumb_upLike (29)
commentReply (3)
thumb_up29 likes
comment
3 replies
M
Mason Rodriguez 7 minutes ago
Some individuals with type 3 have other disabilities or need assistive devices, such as wheelchairs,...
H
Hannah Kim 13 minutes ago
Factors affecting prognosis
With early treatment, the prognosis of SMA may improve, and people can s...
Some individuals with type 3 have other disabilities or need assistive devices, such as wheelchairs, but the condition does not affect their life expectancy. SMA type 4
SMA type 4 is the least severe form of the disease, and people with this type may only have minimal mobility impairments. The life expectancy of someone with type 4 is similar to that of individuals without SMA.
thumb_upLike (45)
commentReply (1)
thumb_up45 likes
comment
1 replies
V
Victoria Lopez 16 minutes ago
Factors affecting prognosis
With early treatment, the prognosis of SMA may improve, and people can s...
A
Alexander Wang Member
access_time
100 minutes ago
Wednesday, 07 May 2025
Factors affecting prognosis
With early treatment, the prognosis of SMA may improve, and people can survive for longer than those who do not receive treatment. Some factors affecting survival in the most severe types, which were once fatal, include: starting treatment before the age of 2 yearsnot having severe symptoms at the time therapy begins responding well to treatmentmanaging health complications, such as infections
Improving life expectancy with SMA
Gene therapy may improve the life expectancy of someone with SMA. However, this technique is very new, and clinical trials have not lasted long enough to determine the average life expectancy following gene therapy.
thumb_upLike (31)
commentReply (1)
thumb_up31 likes
comment
1 replies
Z
Zoe Mueller 28 minutes ago
Rispidlam and nusinersen, two other new drugs, can also extend the lifespan and improve the quality ...
Z
Zoe Mueller Member
access_time
84 minutes ago
Wednesday, 07 May 2025
Rispidlam and nusinersen, two other new drugs, can also extend the lifespan and improve the quality of life for people with SMA. However, like gene therapy, these treatments are new, and it is unclear exactly how long they might prolong a person’s life. In the most severe forms of SMA, the outlook is better if someone receives treatment before developing symptoms.
thumb_upLike (24)
commentReply (1)
thumb_up24 likes
comment
1 replies
I
Isaac Schmidt 55 minutes ago
Learn more about gene therapy for SMA. Summary
There are five types of SMA, ranging from most severe...
A
Audrey Mueller Member
access_time
44 minutes ago
Wednesday, 07 May 2025
Learn more about gene therapy for SMA. Summary
There are five types of SMA, ranging from most severe to least severe.
thumb_upLike (11)
commentReply (0)
thumb_up11 likes
N
Noah Davis Member
access_time
69 minutes ago
Wednesday, 07 May 2025
Most forms cause significant disability and mobility impairments, though people with type 4 sometimes have only mild symptoms. Life expectancy depends on the SMA type a person has, which treatments they are eligible for, and how early they begin them. Parents or caregivers of children with SMA should seek specialist care from an expert and advocate for early intervention, especially if the child is eligible for gene therapy.
thumb_upLike (39)
commentReply (2)
thumb_up39 likes
comment
2 replies
S
Scarlett Brown 30 minutes ago
Adults with SMA should continue to seek care from an expert healthcare team and ask about emerging a...
K
Kevin Wang 19 minutes ago
We link primary sources — including studies, scientific references, and statistics — within each...
G
Grace Liu Member
access_time
120 minutes ago
Wednesday, 07 May 2025
Adults with SMA should continue to seek care from an expert healthcare team and ask about emerging and experimental therapies. Last medically reviewed on September 12, 2022GeneticsRespiratoryNeurology / NeurosciencePediatrics / Children's Health 5 sourcescollapsedMedical News Today has strict sourcing guidelines and draws only from peer-reviewed studies, academic research institutions, and medical journals and associations. We avoid using tertiary references.
thumb_upLike (34)
commentReply (1)
thumb_up34 likes
comment
1 replies
N
Noah Davis 115 minutes ago
We link primary sources — including studies, scientific references, and statistics — within each...
C
Chloe Santos Moderator
access_time
75 minutes ago
Wednesday, 07 May 2025
We link primary sources — including studies, scientific references, and statistics — within each article and also list them in the resources section at the bottom of our articles. You can learn more about how we ensure our content is accurate and current by reading our editorial policy.Burr, P., et al.
(2022). Spinal muscle atrophy.https://www.ncbi.nlm.nih.gov/books/NBK560687/Emmady, P.
thumb_upLike (25)
commentReply (1)
thumb_up25 likes
comment
1 replies
H
Henry Schmidt 47 minutes ago
D., et al. (2022)....
A
Andrew Wilson Member
access_time
81 minutes ago
Wednesday, 07 May 2025
D., et al. (2022).
thumb_upLike (47)
commentReply (2)
thumb_up47 likes
comment
2 replies
V
Victoria Lopez 16 minutes ago
Werdnig Hoffman disease.https://www.ncbi.nlm.nih.gov/books/NBK558933/Reilly, A., et al. (2022). Curi...
I
Isaac Schmidt 41 minutes ago
(2018). Putting our best foot forward: Clinical, treatment-based and ethical considerations of nusin...
E
Ella Rodriguez Member
access_time
140 minutes ago
Wednesday, 07 May 2025
Werdnig Hoffman disease.https://www.ncbi.nlm.nih.gov/books/NBK558933/Reilly, A., et al. (2022). Curing SMA: Are we there yet?https://www.nature.com/articles/s41434-022-00349-yVukovic, S., et al.
thumb_upLike (26)
commentReply (1)
thumb_up26 likes
comment
1 replies
N
Nathan Chen 9 minutes ago
(2018). Putting our best foot forward: Clinical, treatment-based and ethical considerations of nusin...
C
Chloe Santos Moderator
access_time
87 minutes ago
Wednesday, 07 May 2025
(2018). Putting our best foot forward: Clinical, treatment-based and ethical considerations of nusinersen therapy in Canada for spinal muscular atrophy [Abstract].https://onlinelibrary.wiley.com/doi/abs/10.1111/jpc.14226Wadman, R.
thumb_upLike (9)
commentReply (0)
thumb_up9 likes
C
Christopher Lee Member
access_time
30 minutes ago
Wednesday, 07 May 2025
I., et al. (2020).
thumb_upLike (23)
commentReply (2)
thumb_up23 likes
comment
2 replies
D
David Cohen 23 minutes ago
Drug treatment for spinal muscular atrophy types II and III.https://www.cochranelibrary.com/cdsr/doi...
T
Thomas Anderson 14 minutes ago
Their unusually large neuronsOmega-3 may provide a brain boost for people in midlifeSeasonal affecti...
J
Jack Thompson Member
access_time
31 minutes ago
Wednesday, 07 May 2025
Drug treatment for spinal muscular atrophy types II and III.https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006282.pub5/fullFEEDBACK:Medically reviewed by Heidi Moawad, M.D. — By Zawn Villines on September 12, 2022
Latest newsWhat sets 'SuperAgers' apart?
thumb_upLike (30)
commentReply (3)
thumb_up30 likes
comment
3 replies
K
Kevin Wang 14 minutes ago
Their unusually large neuronsOmega-3 may provide a brain boost for people in midlifeSeasonal affecti...
R
Ryan Garcia 24 minutes ago
It replaces the damaged SMN1 gene that causes SMA with a…READ MOREAll about spinal muscular atroph...
Their unusually large neuronsOmega-3 may provide a brain boost for people in midlifeSeasonal affective disorder (SAD): How to beat it this fall and winterCDC: Monkeypox in the US 'unlikely to be eliminated in the near future'Why are more women prone to Alzheimer's? New clues arise
Related CoverageWhat to know about SMA gene therapy
Gene therapy may be a treatment option for some people with spinal muscular atrophy (SMA).
thumb_upLike (19)
commentReply (3)
thumb_up19 likes
comment
3 replies
H
Harper Kim 11 minutes ago
It replaces the damaged SMN1 gene that causes SMA with a…READ MOREAll about spinal muscular atroph...
S
Scarlett Brown 8 minutes ago
Learn more.READ MOREWhat is the best medication for spinal arthritis? Medication can help reduce pai...
It replaces the damaged SMN1 gene that causes SMA with a…READ MOREAll about spinal muscular atrophy (SMA)Medically reviewed by Heidi Moawad, MD
Spinal muscular atrophy (SMA) is a collection of inherited neuromuscular diseases. Muscle weakness is the main symptom, and this can affect breathing…READ MOREWhat is muscular dystrophy?Medically reviewed by Angela M. Bell, MD, FACP
Muscular dystrophy is one of a group of genetic diseases characterized by progressive weakness and muscle degeneration.
thumb_upLike (3)
commentReply (0)
thumb_up3 likes
A
Alexander Wang Member
access_time
136 minutes ago
Wednesday, 07 May 2025
Learn more.READ MOREWhat is the best medication for spinal arthritis? Medication can help reduce pain and improve mobility for people with spinal arthritis.
thumb_upLike (18)
commentReply (1)
thumb_up18 likes
comment
1 replies
S
Scarlett Brown 27 minutes ago
Common types include acetaminophen (Tylenol) and nonsteroidal…READ MOREAll about autonomic dysrefl...
A
Aria Nguyen Member
access_time
70 minutes ago
Wednesday, 07 May 2025
Common types include acetaminophen (Tylenol) and nonsteroidal…READ MOREAll about autonomic dysreflexia
Autonomic dysreflexia (AD) is a life threatening condition resulting from a spinal cord injury. Learn more about autonomic dysreflexia here.
thumb_upLike (25)
commentReply (1)
thumb_up25 likes
comment
1 replies
N
Nathan Chen 13 minutes ago
READ MORE...
A
Amelia Singh Moderator
access_time
180 minutes ago
Wednesday, 07 May 2025
READ MORE
thumb_upLike (30)
commentReply (2)
thumb_up30 likes
comment
2 replies
A
Alexander Wang 111 minutes ago
Spinal muscular atrophy (SMA) life expectancy: Types 0, 1, 2, 3, and 4 Health ConditionsHealth Condi...
J
James Smith 92 minutes ago
The above information comes from a 2018 study in the Journal of Pediatrics and Child Health. It is i...